Stocktoria

AMETEK INC/ AME

AMETEK INC/ (AME) earns a Piotroski F-score of 5/9 (mixed financial health), with an Altman Z″ in the safe zone. It pays a dividend yielding 0.52% (safety: safe). FY2025 revenue was $7.4B at a 20.0% net margin.

Chart by TradingView
74/100
Stocktoria Quality Score · grade A
5/9
Piotroski F — financial health
5.41
Altman Z″ — distress risk · safe
0.6%
Dividend yield 5y avg · safe · Dividend payout 19.3%
-2.43
Beneish M-score — earnings quality · low

Quality score trend · recomputed for each fiscal year

Piotroski F /9
5 7 5 5 5 5 7 4 7 5 2016201720182019202020212022202320242025
Altman Z″
4.59 4.66 4.41 4.45 5.23 4.65 5.23 4.35 5.54 5.41 2016201720182019202020212022202320242025

Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.

$258.52 as of 2026-08-01 · +39.9% 1y
$184.80$258.5252-wk

Beneish M-score: -2.43 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.

Market cap USD$54.4B
P / E36.8×
Dividend yield 5y avg0.6%
Net margin 5y avg19.3%
Return on equity 5y avg14.6%
Beta1
Employees22,500

Analyst price target

$277.22 +7.2% vs last
consensus: buy · 18 analysts
target range $217.00 – $316.00 · median $281.00
2 strong buy · 12 buy · 5 hold · 1 strong sell
Recent analyst actions
DateFirmRating
2026-08-06Truist SecuritiesBuy (main)
2026-08-05DA DavidsonBuy (main)
2026-08-05CitigroupNeutral (main)
2026-08-05BNP ParibasOutperform (main)
2026-08-05RBC CapitalOutperform (main)
2026-08-05KeybancOverweight (main)

Wall Street analyst consensus — a sentiment gauge, not our scoring.

Forward estimates · earnings calendar →

Forward EPS est.$8.98
Forward P / E28.8×
Next ex-dividend2026-09-15

Consensus analyst estimates and scheduled dates — forward-looking, may change.

Smart money · insiders, last 12 months

Insiders net sold -$114,893 on the open market · 1 trades

Open-market insider purchases minus sells (SEC Form 4) — real buying with their own money is a bullish “smart money” signal; grants and option exercises are excluded.

Revenue trend · last 10y · up

How it ranks in Manufacturing · percentile among 1957 companies

Piotroski Fstronger than 63%
Net marginstronger than 93%
Return on equitystronger than 81%
Revenue growthstronger than 55%

Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.

Piotroski F breakdown · 5/9 tests passed

Altman Z″ components · safe zone

ComponentValue
Working capital / assets0.011
Retained earnings / assets0.763
EBIT / assets0.119
Equity / liabilities1.954

Sector peers · similar-size Manufacturing companies compare side by side →

TickerCompanyPiotroski FAltman Z″P / ERevenue growth
AMEAMETEK INC/5/95.4136.8+6.6%
ROPROPER TECHNOLOGIES INC5/93.1422.2+12.3%
KEYSKeysight Technologies, Inc.5/95.1566.1+8%
FTVFortive Corp6/92.8532.4+1.9%
MKSIMKS INC6/92.3289+9.6%
STSensata Technologies Holding plc5/93.27217.7-5.8%
RALRalliant Corp3/9-2.76-4%

All Manufacturing companies →

About AMETEK INC/

AMETEK, Inc. manufactures and sells electronic instruments (EIG) and electromechanical (EMG) devices in the United States and internationally. It operates through EIG and EMG segments. The company offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and metering devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and gas turbines sensors; dashboard instruments for heavy trucks and other vehicles; instrumentation and controls for food and beverage industries; and aircraft and engine sensors, embedded computing, monitoring, power supplies, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry. It also provides engineered medical components and devices, automation solutions, thermal management systems, specialty metals, and electrical interconnects; single-use and consumable surgical instruments, implantable components, and drug delivery systems; engineered electrical connectors and electronics packaging; precision motion control products for data storage, medical devices, business equipment, automation, and other application; high-purity powdered metals, strips and foils, specialty clad metals, and metal matrix composites; motor-blower systems and heat exchangers for thermal management, military and commercial aircraft, and military ground vehicles; and motors used in commercial appliances, food and beverage machines, hydraulic pumps, and industrial blowers, as well as operates a network of aviation maintenance, repair, and overhaul facilities. AMETEK, Inc. was incorporated in 1930 and is headquartered in Berwyn, Pennsylvania.

FAQ

Is AME financially healthy?

AMETEK INC/'s Piotroski F-score is 5/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.

Does AME pay a dividend, and is it safe?

Yes. AMETEK INC/ pays a dividend yielding about 0.52% with a 19.3% payout ratio, rated “safe” for safety.

How profitable is AME?

In FY2025, AMETEK INC/ had a net margin of 20.0% and a return on equity of 13.9%.

Is AME overvalued or undervalued?

AMETEK INC/ trades at about 40.4× trailing earnings — above its 10-year norm (10-year range 21.8×–35.0×, median 28.9×). Stocktoria reports the data, not buy/sell advice.

What is the analyst price target for AME?

The average Wall-Street price target for AMETEK INC/ is $277.22, about 7.2% above the recent price, from 18 analysts (consensus: buy).

Is AME a good stock to buy?

Stocktoria doesn't give buy or sell advice, but here is the data on AMETEK INC/: a Piotroski F-score of 5/9, an Altman Z″ in the safe zone, a P/E of about 36.8×, a dividend yield of 0.52%. Weigh these quality and valuation signals against your own goals.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.